Twice-Weekly Dialysis May Preserve Residual Kidney Function
Patients with preserved residual kidney function experience a survival benefit.
Patients with preserved residual kidney function experience a survival benefit.
Study finds a 20% to 25% lower risk for early death over the long term.
Risk of being admitted for non-cancer conditions is 38% higher in the year after a PCa diagnosis compared with a year before.
Ablating only the prostate lobe with the tumor resulted in satisfactory mid-term functional outcomes, researchers reported.
ERA-EDTA offers guidance on selecting patients for treatment, when to start the drug, dosing strategies, and other aspects of care.
In a study, the arrhythmia was 31% more likely to occur in PKD patients than non-PKD control patients.
Chronic kidney disease found to be 58% more likely to develop in individuals with than without the sleep disorder.
New findings suggest the medication induces beneficial renal structural changes.
In a phase 2 trial, roxadustat maintained hemoglobin levels over 19 weeks as well as epoetin alfa.
Tumors fall into 1 of 5 grade groups based on what pathologic findings indicate about prognosis.